| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |